These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1954991)

  • 41. High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
    Cimino G; Avvisati G; Amadori S; Di Gregorio AO; Magliocca V; Petrucci MT; Sgadari C
    Nouv Rev Fr Hematol (1978); 1989; 31(5):329-32. PubMed ID: 2587201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.
    Bataille R; Boccadoro M; Klein B; Durie B; Pileri A
    Blood; 1992 Aug; 80(3):733-7. PubMed ID: 1638024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Zdzisińska B; Wejksza K; Walter-Croneck A; Turski WA; Kandefer-Szerszeń M
    Leuk Res; 2010 Jan; 34(1):38-45. PubMed ID: 19596432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy-specific beta 1-glycoprotein in serum in monoclonal gammopathies: relationship with serum beta 2-microglobulin, and cellular origin.
    Fagnart OC; Tasiaux N; Masson PL
    Clin Chem; 1986 Dec; 32(12):2150-4. PubMed ID: 3096609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.
    Bartl R; Frisch B; Diem H; Mündel M; Fateh-Moghadam A
    Eur J Haematol Suppl; 1989; 51():88-98. PubMed ID: 2697597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum neopterin--possible immunological marker of myocardial inflammation in patients with dilated heart muscle disease.
    Samsonov M; Nassonov E; Kostin S; Samko A; Alexandrova L; Masenko V; Naumov V; Mareev V; Shevlyagin S; Zhdanov V
    Eur Heart J; 1991 Aug; 12 Suppl D():151-3. PubMed ID: 1915446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective study of the association of serum neopterin, beta 2-microglobulin, and hepatitis B surface antigenemia with death in infants and children with HIV-1 disease.
    Di Franco MJ; Zaknun D; Zaknun J; Vuja E; Oswald HP; Mayersbach P; Hunter D; Tosteson TD; Trichopoulos D; Schmitzberger R
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1079-85. PubMed ID: 8083826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia.
    Benfield TL; Schattenkerk JK; Hofmann B; Jensen BN; Nielsen TL; Lundgren JD
    J Infect Dis; 1994 May; 169(5):1170-3. PubMed ID: 8169417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?
    Chan MM; Campos JM; Josephs S; Rifai N
    J Clin Microbiol; 1990 Oct; 28(10):2215-9. PubMed ID: 2229344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma].
    Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P
    Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma.
    Luoni R; Ucci G; Riccardi A; Gobbi P; Avato FM; Vignale C; Ascari E
    Cancer; 1992 Mar; 69(6):1368-72. PubMed ID: 1540874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up.
    Lambin P; Lefrere JJ; Doinel C; Fine JM; Salmon D; Salmon C
    Clin Chem; 1988 Jun; 34(6):1367-8. PubMed ID: 3288377
    [No Abstract]   [Full Text] [Related]  

  • 57. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
    Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
    Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias.
    Ohtani K; Ninomiya H; Hasegawa Y; Kobayashi T; Kojima H; Nagasawa T; Abe T
    Br J Haematol; 1995 Sep; 91(1):116-20. PubMed ID: 7577617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.